Butterfly Network Announces Commercial Agreement with Mendaera for Next-Generation Interventional Robotic System Powered by Butterfly's Ultrasound-on-Chip™ Technology
19 Dicembre 2023 - 2:05PM
Business Wire
- Agreement with Mendaera represents the first Powered by
Butterfly™ commercialization partnership.
- Partnership will bring Butterfly’s Ultrasound-on-Chip™ to the
robotic intervention market, with revenue anticipated from every
unit sold upon commercialization.
- Mendaera is the latest innovation from the team that previously
exited Auris to Johnson & Johnson.
Butterfly Network, Inc. (“Butterfly”) (NYSE: BFLY), a digital
health company transforming care through the power of portable,
semiconductor-based ultrasound technology and intuitive software,
and Mendaera, a Silicon Valley-based company developing technology
to help healthcare providers more easily and confidently perform
procedures through the power of medical robotics, today announced
an agreement to commercialize a novel robotic system that is
Powered by Butterfly’s Ultrasound-on-Chip™ technology. Upon
commercialization, the deal includes revenue share for every unit
sold.
Mendaera’s robotic technology is compatible with Butterfly’s
proprietary semiconductor-based ultrasound device and connected via
Butterfly’s software development kit – Butterfly Garden™ – creating
a system designed to improve precision and consistency for a broad
range of image-guided, needle-based interventions. This new
category of robotics will increase access to high quality
interventional treatment, ultimately aiming to streamline patient
care within a healthcare system burdened by workforce shortages and
burnout. Both companies anticipate FDA submission of the product by
2025.
“Mendaera’s robotic system is perfectly suited to leverage
Butterfly’s proprietary Ultrasound-on-Chip™ by benefiting from the
wide array of ultrasonic sensing applications that only our chip
can offer,” said Darius Shahida, Chief Strategy Officer of
Butterfly Network. “We are excited to welcome the Mendaera team as
a Powered by Butterfly partner and believe our joint solution will
expand Butterfly’s reach and clinical impact into the
interventional space.”
“At Mendaera, we envision a world where high-quality
intervention is available at every care facility, for each and
every patient encounter. It was a clear choice for us to
collaborate with Butterfly on our technology roadmap, given their
unique and programmable Ultrasound-on-Chip™ platform and aligned
mission to make ultrasonic imaging and intervention ubiquitous,”
said Josh DeFonzo, Co-Founder and CEO of Mendaera.
The news follows Mendaera’s August 2023 announcement of securing
$24 million in Series A Funding, led by Lux Capital, with
participation from Founders Fund, Operator Partners, Allen &
Company, and Parade Ventures. Mendaera has also announced
completion of the research and design process for this novel
robotic system.
To learn more about Butterfly Garden™ or Powered by Butterfly™,
visit: https://www.butterflynetwork.com/butterfly-garden.
About Butterfly Network
Founded by Dr. Jonathan Rothberg in 2011 and listed on the New
York Stock Exchange through a business combination with Longview
Acquisition Corp., Butterfly created the world's first handheld,
single probe whole-body ultrasound system using semiconductor
technology, the Butterfly iQ+. Butterfly's mission is to
democratize medical imaging and contribute to the aspiration of
global health equity, making high-quality ultrasound affordable,
easy-to-use, globally accessible, and intelligently connected,
including for the 4.7 billion people around the world lacking
access to ultrasound. Through its proprietary Ultrasound-on-Chip™
technology, Butterfly is paving the way for earlier detection and
remote management of health conditions around the world. The
Butterfly iQ+ can be purchased today by trained healthcare
practitioners in areas including, but not limited to, parts of
Africa, Asia, Australia, Europe, North America and South America;
to learn more about available countries, visit:
butterflynetwork.com/choose-your-country.
About Mendaera
Mendaera’s vision is to digitize clinical judgment and technical
expertise making high-quality care available for every patient at
every care facility. Its platform combines robotics, real-time
imaging, artificial intelligence, and connectivity to enable
intervention at scale.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20231219290743/en/
Butterfly Business & Technology Inquiries: Darius Shahida,
Chief Business Development Officer dshahida@butterflynetinc.com
Butterfly Media: Liz Learned, Head of Corporate Communications
media@butterflynetwork.com Butterfly Investors: Heather Getz, Chief
Financial and Operations Officer investors@butterflynetwork.com
Grafico Azioni Butterfly Network (NYSE:BFLY)
Storico
Da Apr 2024 a Mag 2024
Grafico Azioni Butterfly Network (NYSE:BFLY)
Storico
Da Mag 2023 a Mag 2024